Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CMO Joanne M. Donovan sold 3,682 shares of Edgewise Therapeutics stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $18.91, for a total transaction of $69,626.62. Following the transaction, the chief marketing officer now directly owns 19,897 shares of […]
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CEO Kevin Koch sold 3,152 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $18.91, for a total transaction of $59,604.32. Following the sale, the chief executive officer now directly owns 14,478 shares in the […]
Piper Sandler assumed coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $48.00 price target on the stock. Separately, Wedbush dropped their target price on Edgewise Therapeutics from $27.00 to $23.00 and set an […]
By Colin Kellaher Edgewise Therapeutics shares moved higher in premarket trading Tuesday after the clinical-stage biopharmaceutical company won U.S. Food and.
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) insider Behrad Derakhshan sold 4,600 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $20.01, for a total transaction of $92,046.00. Following the completion of the sale, the insider now directly owns 7,020 […]